This is the first preclinical study to examine the anti-depressive effects of ibogaine and noribogaine.
This technology developed by MindMed and Liechti Lab may help ease some of the concerns surrounding psychedelic therapy.
Understanding the structure of this synthetic analog of 5-MeO-DMT may help explain the effects of naturally occurring chemical cocktails.
New crystalline forms of norpsilocin create new options for developing psychedelic drug formulations.
5-HT2C has a role in the psychedelic effect. Understanding it is essential for harnessing the full benefits of nature’s chemical cocktails.
Understanding brain morphology differences may prove essential for creating effective psychedelic drug formulations.
Morris has insightful ideas for studying psychedelic toad secretions while prioritizing the conservation of toads.
Environment and diet may play a role in the alkaloid content of secretions from a Brazilian toad species.
Researchers took the psilocybin-making genes from P. cubensis and put them into S. cerevisiae allowing them to produce psilocybin, several of its analogs, and a “new to nature” compound.
Results support the idea that serotonin 5-HT2A receptor-directed therapeutic strategies may be superior to ketamine-based treatments for depression.